Toshio Kokuryo
Overview
Explore the profile of Toshio Kokuryo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
677
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kokuryo T, Koike Y, Yamaguchi J, Sunagawa M, Baba T, Watanabe N, et al.
Cancer Genomics Proteomics
. 2025 Feb;
22(2):346-353.
PMID: 39993799
Background/aim: Metachronous biliary tract cancer (BTC) is a rare occurrence after curative resection of primary BTC. The genetic alterations and pathogenesis associated with metachronous BTC remain poorly understood. Patients And...
2.
Ushida Y, Watanabe N, Kawakatsu S, Yamamoto R, Mizuno T, Onoe S, et al.
Ann Surg
. 2025 Feb;
PMID: 39957618
Objective: To propose a shared T classification system for biliary cancers located around the cystic duct junction. Summary Background Data: These cancers include perihilar cholangiocarcinoma (PCC), distal cholangiocarcinoma (DCC), and...
3.
Nonaka Y, Baba T, Sugita S, Miyata K, Sunagawa M, Yamaguchi J, et al.
Anticancer Res
. 2025 Jan;
45(2):781-787.
PMID: 39890167
Background/aim: Available data on the immune profiles of regional lymph nodes in individuals with esophageal squamous cell carcinoma (ESCC) are limited. This study investigated the immune profiles of proximal regional...
4.
Kokuryo T, Sunagawa M, Yamaguchi J, Baba T, Kawakatsu S, Watanabe N, et al.
Cancer Genomics Proteomics
. 2024 Dec;
22(1):34-40.
PMID: 39730184
Background/aim: Bile tract cancer (BTC) is a malignant tumor with a poor prognosis. Recent studies have reported the heterogeneity of the genomic background and gene alterations in BTC, but its...
5.
Jinno T, Yamaguchi J, Ogura A, Kokuryo T, Yokoyama Y, Sunagawa M, et al.
Anticancer Res
. 2024 Aug;
44(9):3757-3769.
PMID: 39197918
Background/aim: Recent studies suggest that PD-L1 expression in immune cells, rather than tumor cells, plays a key role in tumor immunity. Trefoil factor family 1 (TFF1) is a secreted protein...
6.
Koike Y, Kokuryo T, Yamaguchi J, Sunagawa M, Ogura A, Watanabe N, et al.
Anticancer Res
. 2024 Jun;
44(7):2827-2836.
PMID: 38925844
Background/aim: A deep ultraviolet (DUV) light-emitting diode (LED) is a device that can irradiate electromagnetic waves from 250 nm to 350 nm. Tousled-like kinase 1 (TLK1) encodes a nuclear serine/threonine...
7.
Yamaguchi J, Kokuryo T, Yokoyama Y, Oishi S, Sunagawa M, Mizuno T, et al.
Cancer Med
. 2024 Jun;
13(11):e7395.
PMID: 38872370
Background And Aims: Pancreatic cancer is one of the most lethal malignancies, partly due to resistance to conventional chemotherapy. The chemoresistance of malignant tumors is associated with epithelial-mesenchymal transition (EMT)...
8.
Kage H, Akiyama N, Chang H, Shinozaki-Ushiku A, Ka M, Kawata J, et al.
Cancer Sci
. 2024 Jan;
115(3):954-962.
PMID: 38273803
In Japan, comprehensive genomic profiling (CGP) tests have been reimbursed under the national health care system for solid cancer patients who have finished standard treatment. More than 50,000 patients have...
9.
Human resources for administrative work to carry out a comprehensive genomic profiling test in Japan
Kage H, Oda K, Muto M, Tsuchihara K, Okita N, Okuma Y, et al.
Cancer Sci
. 2023 May;
114(7):3041-3049.
PMID: 37165760
Comprehensive genomic profiling (CGP) tests have been nationally reimbursed in Japan since June 2019 under strict restrictions, and over 46,000 patients have taken the test. Core Hospitals and Designated Hospitals...
10.
Kano M, Kokuryo T, Baba T, Yamazaki K, Yamaguchi J, Sunagawa M, et al.
Anticancer Res
. 2023 Feb;
43(3):1009-1016.
PMID: 36854520
Background/aim: α-Bisabolol is an essential oil component extracted from plants, such as chamomile. We have previously reported that α-bisabolol suppressed proliferation, invasion, and motility of pancreas cancer. Cyclodextrin improved the...